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Abstract: The human body is constantly under attack from free radicals that occur as part 
of normal cell metabolism, and by exposure to environmental factors such as UV light, 
cigarette smoke, environmental pollutants and gamma radiation. The resulting “Reactive 
Oxygen Species” (ROS) circulate freely in the body with access to all organs and tissues, 
which can have serious repercussions throughout the body. The body possesses a number 
of mechanisms both to control the production of ROS and to cope with free radicals in 
order to limit or repair damage to tissues. Overproduction of ROS or insufficient defense 
mechanisms leads to a dangerous disbalance in the organism. Thereby several 
pathomechanisms implicated in over 100 human diseases, e.g., cardiovascular disease, 
cancer, diabetes mellitus, physiological disease, aging, etc., can be induced. Thus, a 
detailed investigation on the quantity of oxygen radicals, such as hydroxyl radicals (OH
●)
 
in human serum blood, and its possible correlation with antioxidant therapy effects, is 
highly topical. The subject of this study was the influence of schizophrenia on the amount 
of OH
● in human serum blood. The radicals were detected by fluorimetry, using 
terephthalic acid as a chemical trap. For all experiments the serum blood of healthy people 
was used as a control group. 
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1. Introduction  
Mental disorders like drug abuse, depression, schizophrenia, etc. are increasingly affecting societies 
worldwide. Clinical schizophrenia is connected with a number of vegetative, psychological and 
biochemical processes in a human organism [1]. One of the current focuses in this field of research is 
the investigation of the relation of various malfunctions caused by mental disorders like   
schizophrenia [1,2].  
Schizophrenia affects men and women equally. It occurs at similar rates in all ethnic groups around 
the world. Symptoms such as hallucinations and delusions usually start between ages 16 and 30. It can 
be difficult to diagnose schizophrenia in teens. This is because the first signs can include a change of 
friends, a drop in grades, sleep problems, and irritability—behaviors that are common among 
teenagers [3]. 
Schizophrenia is caused by several factors. Scientists have long known that schizophrenia runs in 
families. The illness occurs in 1 percent of the general population, but it occurs in 10 percent of people 
who have a first-degree relative with the disorder, such as a parent, brother, or sister. Other recent 
studies suggest that schizophrenia may result in part when a certain gene, that is key to making 
important brain chemicals, malfunctions. This problem may affect the part of the brain involved in 
developing higher functioning skills. In addition, it probably takes more than genes to cause the 
disorder. Scientists think interactions between genes and the environment are necessary for 
schizophrenia to develop. Many environmental factors may be involved, such as exposure to viruses or 
malnutrition before birth, problems during birth, and other not yet known psychosocial factors [4,5]. 
Scientists think that an imbalance in the complex, interrelated chemical reactions of the brain 
involving the neurotransmitters dopamine and glutamate, and possibly others, plays a role in 
schizophrenia. Neurotransmitters are substances that allow brain cells to communicate with each 
other [6]. 
Five sub-classifications of schizophrenia are known [7]: 
•  Paranoid type: Where delusions and hallucinations are present but thought disorder, disorganized 
behavior, and affective flattening are absent.  
•  Disorganized type: Named hebephrenic schizophrenia. Where thought disorder and flat affect are 
present together.  
•  Catatonic type: The subject may be almost immobile or exhibit agitated, purposeless movement. 
Symptoms can include catatonic stupor and waxy flexibility.  
• Undifferentiated type: Psychotic symptoms are present but the criteria for paranoid, 
disorganized, or catatonic types have not been met.  
•  Residual type: Where positive symptoms are present at a low intensity only.  
• Post-schizophrenic  depression: A depressive episode arising in the aftermath of a schizophrenic 
illness where some low-level schizophrenic symptoms may still be present.  Int. J. Mol. Sci. 2011, 12  
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•  Simple schizophrenia: Insidious and progressive development of prominent negative symptoms 
with no history of psychotic episodes.  
Scientists have learned a lot about schizophrenia, but more research is needed to help explain how it 
develops. The ROS play major role in development of schizophrenia. 
This work will develop better treatment to help people with schizophrenia achieve their 
full potential. 
It is well known that mental illnesses significantly affect the antioxidant protective system of an 
organism which might lead to oxidative damage caused by a rapid growth of free oxygen   
radicals [8–15]. Thus a detailed research of oxygen radical’s quantity in human serum blood under 
pathological conditions (schizophrenia)  and the investigation of its possible correlation with 
antioxidant therapy efficiency is highly prospective. 
Detection of OH
● radicals in human serum blood under pathological conditions of schizophrenia 
was carried out by fluorimetry, whereby terephthalic acid (TA) was used as a chemical trap.  
It is known that reactive oxygen species (ROS) are involved in diseases like cancer, atherosclerosis, 
hepatocirrhosis, psychotropic diseases, etc. Direct detection of ROS is practically impossible because 
of their extreme reactivity and very short lifetime. This led to the development of chemical traps to 
facilitate their quantitative detection [16], where the potential of ROS to oxidize a chemical trap is 
defined as Fenton activity. The most commonly used procedure is based on the hydroxylation of 
salicylic acid, which is based on the chemical reaction shown in Scheme 1: 
Scheme 1. Hydroxylation of Salicylic acid. 
 
 
 
However, some authors [17,18] have questioned its validity. Accurate quantitative estimation of 
ROS formation could be achieved only if all three hydroxylation products are considered. However, 
species I, as it is produced only in small amounts is usually neglected in the analysis. Even so, under 
the assumption of a constant ratio of the hydroxylation products, it should still be possible to obtain 
reliable ROS quantification by taking two or even only one derivative. Recent experiments in our 
laboratories, however, confirmed by several results from the literature, have shown that there is time 
dependence and, moreover, strong influence of chemical environment on the product ratio, affecting 
even in vitro results. Several additional problems arise under in vivo conditions. Species II is also 
produced enzymatically, leaving only species III available for detection as a simple ROS product. As 
the ratio between species III and species II varies from 5:1 to 1:1 the resulting quantization error is far 
from being negligible. Moreover, species III is quite unstable and, in common with the other species, 
quickly metabolized. Furthermore, salicylic acid itself is biologically active and could influence 
inflammatory processes associated with oxidative stress, thus directly affecting the results. 
W. Freinbichler and Prof. W. Linert et al. [19] developed a new fluorimetric method for detection 
of ROS, using terephthalic acid (Н2ТА) as a chemical trap. Formation of ROS like OH
● radicals can be 
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detected by the ROS producing model reaction like the Fenton reaction [19] (Equation 1), whereby the 
non-fluorescent Н2ТА is hydroxylated to the excellent fluorophor TA-OH. 
Fe
2+ + H2O2→Fe
3+ + 2ОН
·      ( 1 )  
Hydroxylation of terephthalic acid occurs as presented in Scheme 2: 
Scheme 2. Hydroxylation of terephthalic acid due to radical oxidation. 
+ OH
OH
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A big advantage of this system is that, apart from some minor fragmentation products, which occur 
in all aromatic hydroxylation processes, the symmetry of the molecule leads to only one hydroxylated 
product which in contrast to the (quasi) non fluorescent TA
2- gives brilliant fluorescence. 
Based on this system, we were able to develop the method of OH
● radical detection in human serum 
blood in patients with pathological schizophrenia. 
2. Materials and Methods 
To determine the number of OH
● radicals in human serum blood a RF-5301pc 
Spectrofluorophotometer Shimadzu (Germany) was used. The pH values of the solutions were 
monitored using a Theta’90, M-150 pH-meter (Czechia).  
2.1. Preparation of serum sample 
During this study serum blood of 50 healthy males aged from 20 to 30 (without pathology) and 
10 male patients aged from 23 to 42 with paranoid type of schizophrenia (clinical form) treated in 
psychiatric hospital was used. It is known schizophrenia affects men and women equally [3]. In this 
work only the male patients were chosen for investigation. During the experiment blood had been 
tested three times for 10 days. Before the experiments blood centrifuging had been carried out for 
10 minutes at 1500 rpm [20]. 
2.2. Detection of OH
● radical’s concentration in serum blood by fluorimetry 
2.2.1. Preparation of standard solutions 
A standard solution of sodium salt of terephthalic acid (sodium terephthalate Na2TA) with the 
concentration of 1·10
−2 mol/L was prepared by dissolving 0.166 g of terephthalic acid H2TA 
(Technical University of Vienna, Austria) in 100 mL of NaOH (0.01 mol/L). A standard solution of 
Mohr's salt (NH4)2Fe (II) (SO4)2(6H2O) (Merk) with the concentration of 2 × 10
−3 mol/L was 
prepared by dissolving 0.024 g in 50 mL of distilled water. A standard solution of H2O2 with the 
concentration of 1 × 10
−3 mol/L was prepared from a 30% solution (Sigma-Aldrich) by taking 0.05 mL Int. J. Mol. Sci. 2011, 12  
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of that solution into 20 mL of distilled water. The exact concentration of H2O2 was determined by 
titrating it with KMnO4. 
As a supporting solution phosphate buffer (0.025 mol/L, pH = 6.86 (equimolar mixture of Na2PO4 
and KH2PO4) with 2% KCl (for 100 mL of a standard solution of buffer of 2 g of KCl)) was used. 
2.2.2. Detection of OH
● radicals in Fenton system 
Reactive oxygen species (ROS), that exist either as free or bound hydroxyl radicals or Fe(IV) oxo 
species, selectively hydroxylate the non-fluorescent TA to the brilliant fluorophor   
2-hydroxy-terephthalic acid (TA-OH). 
To detect the fluorescence signal of TA-OH in a Fenton system, the following solutions were added 
in a particular order into a cell of 10 mL: —2 mL of standard solution of terephthalate (1·10
−2 mol/L);  
—0.03 mL of standard solution of Mohr's salt (2·10
−3 mol/L); —0.03 mL of standard solution of 
hydrogen peroxide (1·10
−3 mol/L); —2 mL of supporting solution of phosphate buffer at pH = 6.86.  
The remaining volume was adjusted to the mark using distilled water (V = 6.4 mL). The mixture 
was incubated at room temperature for 6 minutes.  
To investigate the quantity of hydroxyl radicals in serum blood, 2 mL of terephthalate   
(1·10
−2 mol/L) standard solution, 2 mL of supporting solution and different volumes of serum from  
0.1 to 0.5 mL were added into the 10 mL cell. The remaining volume of the reaction mixture was 
adjusted to the mark using distilled water. 
Within this work OH
● radicals in serum blood of 10 healthy males and 10 male patients with 
schizophrenia were detected by fluorimetry, using terephthalic acid. Detailed emission spectra have been 
obtained for an excitation wavelength of 315 nm at a pH of 6.86. 
A Fenton system (Equation 1) was used to generate OH
● radicals and the signal of TA-OH was 
measured fluorimetrically.  
3. Results and Discussion 
In Figure 1 the emission spectrum of the reaction product of terephthalic acid with OH
● radicals 
(TA-OH) at λ = 327 nm (see Scheme 2) is presented. These data are in excellent agreement with those 
in [15]. In Figure 2, the dependence on the signal strength of TA-OH on hydrogen peroxide 
concentration (mmol/L) is presented. A linear dependence in the range of Н2О2 concentrations from 
0.1mmol/L to 0.5 mmol/L was observed (Figure 2). For each concentration the three samples of 
hydrogen peroxide were used to obtain each measure. 
For the quantitative detection of OH
● radicals in human serum blood in patients with pathological 
schizophrenia the detected fluorescence spectrum was identical to that of TA-OH with 
λemissionmax = 327 nm (Figure 3) for excitation wavelength of 315 nm at a pH of 6.86. It was concluded 
that TA-OH was the only fluorescing species under these conditions. The received signal increased 
with addition of serum blood (Figure 3).  
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Figure 1. Fluorescence TA-OH in Fenton system at λ = 327 nм. 
 
Figure 2. Dependence on peak intensity of fluorescence TA-OH on hydrogen peroxide 
concentration in the solution. N = 3. 
 
Figure 3. The fluorescence spectrum of TA-OH in human serum blood in patients with 
pathological schizophrenia at = 327 нм. ----0.1 mL of serum blood; ----0.2 mL of serum 
blood; ----0.25 mL of serum blood.  
 
The results lead to the assumption that natural components of human serum blood contain a system 
able to generate active OH
● radicals, which can be defined using fluorimetry. In turn, the controlling Int. J. Mol. Sci. 2011, 12  
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the maintenance of active OH
● radicals in human serum blood will reveal the increase or decrease of 
ROS levels in the blood that can be key to understanding important biochemical processes developed 
in an organism with pathological symptoms of mental illnesses. In Figure 4 the dependence on the 
peak intensity of TA-OH fluorescence on the volume of added human serum blood, taken from healthy 
males and patients with pathological schizophrenia with an identical duration of the illness, is 
presented. All examples show a similar linear behavior. For each volume the three samples of human 
serum blood were used to obtain each measure. 
Figure 4. Dependence on the peak intensity of TA-OH fluorescence on the volume of 
human serum blood of healthy males and patients with pathological schizophrenia.   
---serum blood of healthy male, ---serum blood of patient №1, ---serum blood of patient 
№2,---serum blood of patient №3. N = 3. 
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Table 1. Concentrations of OH
● radicals in serum blood of healthy people and patients 
with pathological schizophrenia. 
The code of the 
patient 
Concentration of OH
● radicals in 
serum blood of healthy people, 
µmol/L 
Concentration of OH
● radicals in 
serum blood of patients with 
schizophrenia, µmol/L 
1  400 ± 2.02  520 ± 2.53 
2  350 ± 1.31  510 ± 2.16 
3  390 ± 1.21  550 ± 4.61 
4  410 ± 3.04  580 ± 2.53 
5  310 ± 3.52  420 ± 2.72 
6  290 ± 1.91  430 ± 1.91 
7  340 ± 3.13  450 ± 2.84 
8  270 ± 2.42  380 ± 4.03 
9  300 ± 2.82  520 ± 4.51 
10  320 ± 4.13  560 ± 3.23 
Thus, in this work, a quantitative detection of active OH
● radicals in serum blood of healthy people 
and patients with pathological schizophrenia by fluorimetry was carried out. Table 1 presents the 
results obtained from 10 healthy patients and with pathological scizophrenia.  Int. J. Mol. Sci. 2011, 12  
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As one can see from Table 1, concentrations of OH
● radicals in serum blood of healthy patients are 
considerably lower than in serum blood of people with pathological schizophrenia. Probably, the high 
content of OH
● radicals in the serum of patients in comparison to healthy people may be due to lipid 
peroxidation of biomembranes of cells during the development of the pathology, resulting in increased 
secretion of OH
● radicals in the blood, which is in excellent agreement with the literature [19]. It is 
known [21,22] that the concentration of peroxide radical in the blood of healthy people is in region of 
200–400 µmol/L, measured photometrically by immune diagnostic assay.  
Thus, the quantity of OH
● radicals in human serum blood under physiological and pathological 
conditions of schizophrenia was determined by fluorimetry. It was revealed that in serum blood of 
healthy people, there are less OH
● radicals generated than in the blood of people suffering from 
schizophrenia. The results clearly show that the presented techniques could be very helpful for clinical 
laboratories for the purpose of operational control for the content of active oxygen radicals in human 
blood, which eventually could lead to a better understanding of important biochemical processes 
taking place in the body with pathological symptoms of mental illnesses. The present technique is very 
simple; therefore, its implementation would be easy for routine use. 
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